Daljeet Kohli has raked in 200% gains from HSIL. The stock has corrected a bit and consolidated. Daljeet has now upgraded the stock from ‘hold’ to ‘buy’ and foreseen more gains from it
IndiaNivesh has issued an ‘Initiating Coverage’ report on Indoco Remedies claiming that the Company can deliver 46% CAGR earnings over FY14-17E and that there is huge upside from the stock
Recent Comments